Whilst current evidence is reassuring regarding cancer risk, certain circumstances warrant specific discussion and potentially alternative treatment approaches
Based on the promising results obtained in cancer and other diseases (57), several miRNAs and lncRNAs were identified and tested in different FXS models (5860), but their potential use in clinical therapy is still far away similarly to the modern application of gene therapy methods to restore the Fmr1 gene (61)
2011, Jul, 30;6(7):106083 Patel DP, Krausz KW, Xie C, Beyolu D, Gonzalez FJ, Idle JR
Patients experiencing persistent or severe side effects should contact their prescribing medical provider for guidance
lesions are deep, tender, or cystic
siRNAs specifically targeting GSDMD and a non-targeting control siRNA were designed and synthesized by Genechem (Shanghai, China)